Atypical mitogen-activated protein kinases: Structure, regulation and functions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 8, 2007, Pages 1376-1387

  Coulombe, Phillipe ^a   Meloche, Sylvain ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Extracellular signal regulated kinase; MAP kinase; Nemo like kinase; Protein phosphorylation; Structure; Substrate specificity

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

CELL DIVISION; CELL LINEAGE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE IDENTIFICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 34547228831     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.11.001     Document Type: Review

References (86)

1. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
2. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 (1999) 143-180
3. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
4. Tanoue T., and Nishida E. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15 (2003) 455-462
5. Morrison D.K., and Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19 (2003) 91-118
6. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
7. Kortenjann M., Nehls M., Smith A.J., Carsetti R., Schuler J., Kohler G., and Boehm T. Abnormal bone marrow stroma in mice deficient for nemo-like kinase, Nlk. Eur. J. Immunol. 31 (2001) 3580-3587
8. Kuida K., and Boucher D.M. Functions of MAP kinases: insights from gene-targeting studies. J. Biochem. (Tokyo) 135 (2004) 653-656
9. Erickson A.K., Payne D.M., Martino P.A., Rossomando A.J., Shabanowitz J., Weber M.J., Hunt D.F., and Sturgill T.W. Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J. Biol. Chem. 265 (1990) 19728-19735
10. Clark-Lewis I., Sanghera J.S., and Pelech S.L. Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266 (1991) 15180-15184
11. Songyang Z., Lu K.P., Kwon Y.T., Tsai L.H., Filhol O., Cochet C., Brickey D.A., Soderling T.R., Bartleson C., Graves D.J., DeMaggio A.J., Hoekstra M.F., Blenis J., Hunter T., and Cantley L.C. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16 (1996) 6486-6493
12. Yoon S., and Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 (2006) 21-44
13. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
14. Abe M.K., Kahle K.T., Saelzler M.P., Orth K., Dixon J.E., and Rosner M.R. ERK7 is an autoactivated member of the MAPK family. J. Biol. Chem. 276 (2001) 21272-21279
15. Klevernic I.V., Stafford M.J., Morrice N., Peggie M., Morton S., and Cohen P. Characterization of the reversible phosphorylation and activation of ERK8. Biochem. J. 394 (2006) 365-373
16. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., and Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65 (1991) 663-675
17. Zhu A.X., Zhao Y., Moller D.E., and Flier J.S. Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3. Mol. Cell. Biol. 14 (1994) 8202-8211
18. Meloche S., Beatty B.G., and Pellerin J. Primary structure, expression and chromosomal locus of a human homolog of rat ERK3. Oncogene 13 (1996) 1575-1579
19. Turgeon B., Saba-El-Leil M.K., and Meloche S. Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa. Biochem. J. 346 Pt. 1 (2000) 169-175
20. Bind E., Kleyner Y., Skowronska-Krawczyk D., Bien E., Dynlacht B.D., and Sanchez I. A novel mechanism for mitogen-activated protein kinase localization. Mol. Biol. Cell 15 (2004) 4457-4466
21. Turgeon B., Lang B.F., and Meloche S. The protein kinase ERK3 is encoded by a single functional gene: genomic analysis of the ERK3 gene family. Genomics 80 (2002) 673-680
22. Gonzalez F.A., Raden D.L., Rigby M.R., and Davis R.J. Heterogeneous expression of four MAP kinase isoforms in human tissues. FEBS Lett. 304 (1992) 170-178
23. S. Meloche, Erk4. AFCS/ Nature Molecule Pages 2006. (doi:10.1038/mp.a000877.01).
24. Peng X., Angelastro J.M., and Greene L.A. Tyrosine phosphorylation of extracellular signal-regulated protein kinase 4 in response to growth factors. J. Neurochem. 66 (1996) 1191-1197
25. Yung Y., Yao Z., Hanoch T., and Seger R. ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J. Biol. Chem. 275 (2000) 15799-15808
26. Krens S.F., He S., Spaink H.P., and Snaar-Jagalska B.E. Characterization and expression patterns of the MAPK family in zebrafish. Gene Expr. Patterns (2006) 1019-1026
27. English J.M., Vanderbilt C.A., Xu S., Marcus S., and Cobb M.H. Isolation of MEK5 and differential expression of alternatively spliced forms. J. Biol. Chem. 270 (1995) 28897-28902
28. Robinson M.J., Cheng M., Khokhlatchev A., Ebert D., Ahn N., Guan K.L., Stein B., Goldsmith E., and Cobb M.H. Contributions of the mitogen-activated protein (MAP) kinase backbone and phosphorylation loop to MEK specificity. J. Biol. Chem. 271 (1996) 29734-29739
29. Kostich M., English J., Madison V., Gheyas F., Wang L., Qiu P., Greene J., and Laz T.M. Human members of the eukaryotic protein kinase family. Genome Biol. 3 (2002) 0043.1-0043.12
30. Canagarajah B.J., Khokhlatchev A., Cobb M.H., and Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90 (1997) 859-869
31. Johnson D.A., Akamine P., Radzio-Andzelm E., Madhusudan M., and Taylor S.S. Dynamics of cAMP-dependent protein kinase. Chem. Rev. 101 (2001) 2243-2270
32. Gibbs C.S., and Zoller M.J. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266 (1991) 8923-8931
33. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.H., and Musacchio A. Structure and regulation of the CDK5-p25(nck5a) complex. Mol. Cell 8 (2001) 657-669
34. Longenecker K.L., Roach P.J., and Hurley T.D. Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition. J. Mol. Biol. 257 (1996) 618-631
35. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
36. Peitsch M.C. ProMod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24 (1996) 274-279
37. Coulombe P., Rodier G., Pelletier S., Pellerin J., and Meloche S. Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation. Mol. Cell. Biol. 23 (2003) 4542-4558
38. Zimmermann J., Lamerant N., Grossenbacher R., and Furst P. Proteasome- and p38-dependent regulation of ERK3 expression. J. Biol. Chem. 276 (2001) 10759-10766
39. Garcia J.I., Zalba G., Detera-Wadleigh S.D., and de Miguel C. Isolation of a cDNA encoding the rat MAP-kinase homolog of human p63mapk. Mamm. Genome 7 (1996) 810-814
40. Mikalsen T., Johannessen M., and Moens U. Sequence- and position-dependent tagging protects extracellular-regulated kinase 3 protein from 26S proteasome-mediated degradation. Int. J. Biochem. Cell Biol. 37 (2005) 2513-2520
41. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
42. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503-533
43. Coulombe P., Rodier G., Bonneil E., Thibault P., and Meloche S. N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 24 (2004) 6140-6150
44. Ciechanover A., and Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14 (2004) 103-106
45. Julien C., Coulombe P., and Meloche S. Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. J. Biol. Chem. 278 (2003) 42615-42624
46. Seternes O.M., Mikalsen T., Johansen B., Michaelsen E., Armstrong C.G., Morrice N.A., Turgeon B., Meloche S., Moens U., and Keyse S.M. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. EMBO J. 23 (2004) 4780-4791
47. Schumacher S., Laass K., Kant S., Shi Y., Visel A., Gruber A.D., Kotlyarov A., and Gaestel M. Scaffolding by ERK3 regulates MK5 in development. EMBO J. 23 (2004) 4770-4779
48. Cheng M., Boulton T.G., and Cobb M.H. ERK3 is a constitutively nuclear protein kinase. J. Biol. Chem. 271 (1996) 8951-8958
49. Cheng M., Zhen E., Robinson M.J., Ebert D., Goldsmith E., and Cobb M.H. Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3. J. Biol. Chem. 271 (1996) 12057-12062
50. Robinson M.J., Xu Be B.E., Stippec S., and Cobb M.H. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo. J. Biol. Chem. 277 (2002) 5094-5100
51. Nolen B., Taylor S., and Ghosh G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15 (2004) 661-675
52. Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A.A., Brown M.J., Smith D.G., and Reith A.D. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9 (2001) 1143-1152
53. Frame S., Cohen P., and Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7 (2001) 1321-1327
54. Nolen B., Yun C.Y., Wong C.F., McCammon J.A., Fu X.D., and Ghosh G. The structure of Sky1p reveals a novel mechanism for constitutive activity. Nat. Struct. Biol. 8 (2001) 176-183
55. Aubol B.E., Chakrabarti S., Ngo J., Shaffer J., Nolen B., Fu X.D., Ghosh G., and Adams J.A. Processive phosphorylation of alternative splicing factor/splicing factor 2. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12601-12606
56. Kleines M., Gartner A., Ritter K., and Schaade L. Early steps in termination of the immortalization state in Burkitt lymphoma: induction of genes involved in signal transduction, transcription, and trafficking by the ganglioside IV(3)NeuAc-nLcOse(4)Cer. Biochim. Biophys. Acta 1492 (2000) 139-144
57. Crowe D.L. Induction of p97MAPK expression regulates collagen mediated inhibition of proliferation and migration in human squamous cell carcinoma lines. Int. J. Oncol. 24 (2004) 1159-1163
58. Anhe G.F., Torrao A.S., Nogueira T.C., Caperuto L.C., Amaral M.E., Medina M.C., Azevedo-Martins A.K., Carpinelli A.R., Carvalho C.R., Curi R., Boschero A.C., and Bordin S. ERK3 associates with MAP2 and is involved in glucose-induced insulin secretion. Mol. Cell. Endocrinol. 251 (2006) 33-41
59. Choi K.W., and Benzer S. Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene. Cell 78 (1994) 125-136
60. Brott B.K., Pinsky B.A., and Erikson R.L. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 963-968
61. Rocheleau C.E., Yasuda J., Shin T.H., Lin R., Sawa H., Okano H., Priess J.R., Davis R.J., and Mello C.C. WRM-1 activates the LIT-1 protein kinase to transduce anterior/posterior polarity signals in C. elegans. Cell 97 (1999) 717-726
62. Meneghini M.D., Ishitani T., Carter J.C., Hisamoto N., Ninomiya-Tsuji J., Thorpe C.J., Hamill D.R., Matsumoto K., and Bowerman B. MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399 (1999) 793-797
63. Ishitani T., Ninomiya-Tsuji J., Nagai S., Nishita M., Meneghini M., Barker N., Waterman M., Bowerman B., Clevers H., Shibuya H., and Matsumoto K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399 (1999) 798-802
64. Yamada M., Ohkawara B., Ichimura N., Hyodo-Miura J., Urushiyama S., Shirakabe K., and Shibuya H. Negative regulation of Wnt signalling by HMG2L1, a novel NLK-binding protein. Genes Cells 8 (2003) 677-684
65. Yamada M., Ohnishi J., Ohkawara B., Iemura S., Satoh K., Hyodo-Miura J., Kawachi K., Natsume T., and Shibuya H. NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J. Biol. Chem. 281 (2006) 20749-20760
66. Kanei-Ishii C., Ninomiya-Tsuji J., Tanikawa J., Nomura T., Ishitani T., Kishida S., Kokura K., Kurahashi T., Ichikawa-Iwata E., Kim Y., Matsumoto K., and Ishii S. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 18 (2004) 816-829
67. Ohkawara B., Shirakabe K., Hyodo-Miura J., Matsuo R., Ueno N., Matsumoto K., and Shibuya H. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes Dev. 18 (2004) 381-386
68. Smit L., Baas A., Kuipers J., Korswagen H., van de Wetering M., and Clevers H. Wnt activates the Tak1/Nemo-like kinase pathway. J. Biol. Chem. 279 (2004) 17232-17240
69. Kojima H., Sasaki T., Ishitani T., Iemura S., Zhao H., Kaneko S., Kunimoto H., Natsume T., Matsumoto K., and Nakajima K. STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4524-4529
70. Ishitani T., Ninomiya-Tsuji J., and Matsumoto K. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-Like-Kinase-dependent phosphorylation in Wnt/b-catenin signaling. Mol. Cell. Biol. 23 (2003) 1379-1389
71. Shin T.H., Yasuda J., Rocheleau C.E., Lin R., Soto M., Bei Y., Davis R.J., and Mello C.C. MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Mol. Cell 4 (1999) 275-280
72. Kim Y.H., Choi C.Y., Lee S.J., Conti M.A., and Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273 (1998) 25875-25879
73. Hurlstone A., and Clevers H. T-cell factors: turn-ons and turn-offs. EMBO J. 21 (2002) 2303-2311
74. Kaletta T., Schnabel H., and Schnabel R. Binary specification of the embryonic lineage in Caenorhabditis elegans. Nature 390 (1997) 294-298
75. Kurahashi T., Nomura T., Kanei-Ishii C., Shinkai Y., and Ishii S. The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol. Biol. Cell 16 (2005) 4705-4713
76. Abe M.K., Kuo W.L., Hershenson M.B., and Rosner M.R. Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol. Cell. Biol. 19 (1999) 1301-1312
77. Abe M.K., Saelzler M.P., Espinosa III R., Kahle K.T., Hershenson M.B., Le Beau M.M., and Rosner M.R. ERK8, a new member of the mitogen-activated protein kinase family. J. Biol. Chem. 277 (2002) 16733-16743
78. Kuo W.L., Duke C.J., Abe M.K., Kaplan E.L., Gomes S., and Rosner M.R. ERK7 expression and kinase activity is regulated by the ubiquitin-proteosome pathway. J. Biol. Chem. 279 (2004) 23073-23081
79. Iavarone C., Acunzo M., Carlomagno F., Catania A., Melillo R.M., Carlomagno S.M., Santoro M., and Chiariello M. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. J. Biol. Chem. 281 (2006) 10567-10576
80. Qian Z., Okuhara D., Abe M.K., and Rosner M.R. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J. Biol. Chem. 274 (1999) 1621-1627
81. Ashley R.H. Challenging accepted ion channel biology: p64 and the CLIC family of putative intracellular anion channel proteins (Review). Mol. Membr. Biol. 20 (2003) 1-11
82. Henrich L.M., Smith J.A., Kitt D., Errington T.M., Nguyen B., Traish A.M., and Lannigan D.A. Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction. Mol. Cell. Biol. 23 (2003) 5979-5988
83. Saelzler M.P., Spackman C.C., Liu Y., Martinez L.C., Harris J.P., and Abe M.K. ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5. J. Biol. Chem. 281 (2006) 16821-16832
84. Fujimoto N., Yeh S., Kang H.Y., Inui S., Chang H.C., Mizokami A., and Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274 (1999) 8316-8321
85. Yang L., Guerrero J., Hong H., DeFranco D.B., and Stallcup M.R. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11 (2000) 2007-2018
86. Drori S., Girnun G.D., Tou L., Szwaya J.D., Mueller E., Xia K., Shivdasani R.A., and Spiegelman B.M. Hic-5 regulates an epithelial program mediated by PPARgamma. Genes Dev. 19 (2005) 362-375